Elevations of intracellular Ca2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposure to methylmercury

Toxicology and Applied Pharmacology
M Sue Marty, W D Atchison

Abstract

In these experiments we examined whether the elevations in intracellular Ca2+ concentration ([Ca2+]i) induced by methylmercury (MeHg)(described in our previous study) might contribute to cerebellar granule cell mortality following exposure to MeHg in vitro. Cells were exposed to 0.5 microM MeHg for 45 min or 1 microM MeHg for 38 min, conditions previously shown to induce elevations in [Ca2+]i in these cells. Control cells were exposed to buffer alone for 60 min. Viability was assessed using the Live/Dead viability/cytotoxicity kit. At 30 min post-MeHg exposure, there was no immediate increase in cell mortality; however, by 3.5 h after the onset of MeHg exposure, cell viability decreased to 74 and 54% of control values for 0.5 and 1.0 microM MeHg, respectively. At 24.5 h after MeHg exposure, cell viability declined to approximately 27%. Losses in cell viability at 3.5 h were prevented by pretreating the granule cells for 65 min with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl)ester (BAPTA; 10 microM), then exposing the cells to MeHg in the continued presence of BAPTA; however, at 24.5 h, BAPTA no longer prevented MeHg-induced cell death. Exposure to the Ca2+ channel blockers ...Continue Reading

References

May 1, 1978·Toxicology and Applied Pharmacology·S OmataH Sugano
Jan 1, 1976·Toxicology and Applied Pharmacology·M S Juang
Jan 1, 1991·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·T Sarafian, M A Verity
Jan 1, 1990·Trends in Pharmacological Sciences·G Zernig
Jun 1, 1990·The Science of the Total Environment·R DietzC T Hansen
Jan 1, 1989·Journal of Neuropathology and Experimental Neurology·T SarafianM A Verity
Jan 1, 1987·Critical Reviews in Toxicology·K Miura, N Imura
Jun 1, 1983·Journal of Applied Toxicology : JAT·S Nakada, N Imura
Jul 1, 1982·Experimental Neurology·P R SagerP M Rodier
Apr 1, 1981·Archives of Toxicology·T L SyversenP R Flood
Oct 1, 1993·Toxicology and Applied Pharmacology·M F DennyW D Atchison
Oct 1, 1994·British Journal of Pharmacology·R S Redman, E M Silinsky
Oct 14, 1994·Biochemical and Biophysical Research Communications·M Kunimoto
Jul 1, 1994·Journal of Neurochemistry·M F Denny, W D Atchison
May 28, 1993·Annals of the New York Academy of Sciences·J M Dubinsky
Dec 1, 1995·Toxicology and Applied Pharmacology·M F Hare, W D Atchison
Oct 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·R LeonhardtD Büsselberg
Jan 24, 1998·Toxicology and Applied Pharmacology·M S Marty, W D Atchison
Nov 1, 1954·Journal of Neurology, Neurosurgery, and Psychiatry·D HUNTER, D S RUSSELL

❮ Previous
Next ❯

Citations

Jan 2, 2001·Neuropathology : Official Journal of the Japanese Society of Neuropathology·F MoriK Wakabayashi
Jan 31, 2012·Journal of Toxicology·Sanah SadiqDietrich Büsselberg
Jan 7, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yukun Yuan, William D Atchison
Apr 20, 2010·Chemico-biological Interactions·Sandra CeccatelliMichaela Moors
Jul 2, 2004·Basic & Clinical Pharmacology & Toxicology·Tsun-Cheng Kuo, Shoei-Yn Lin-Shiau
Mar 19, 2016·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Alessandra Antunes Dos SantosMichael Aschner
Aug 29, 2012·Journal of Biomedicine & Biotechnology·Daniel RoosNilda Vargas Barbosa
Jul 5, 2001·Toxicology and Applied Pharmacology·S R HeidemannW D Atchison
Jan 10, 2002·Toxicology and Applied Pharmacology·Tobi L Limke, William D Atchison
Aug 3, 2016·Behavioural Brain Research·Andrew Nathanael ShenM Christopher Newland
Aug 16, 2011·Neurotoxicology·Gunasekaran Ramanathan, William D Atchison
Dec 11, 2007·International Journal of Toxicology·Jessica N MazerikNarasimham L Parinandi
Jun 24, 2008·International Journal of Toxicology·Tsun-Cheng Kuo
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Jun 15, 2007·International Journal of Toxicology·Sairam BellumLouise C Abbott
Aug 14, 2012·Journal of Applied Toxicology : JAT·Sairam BellumLouise C Abbott
Apr 24, 2007·Neurotoxicity Research·Carolina JohanssonSandra Ceccatelli
Jul 2, 2003·Neurotoxicity Research·Coral SanfeliuEduard Rodríguez-Farré
Jan 1, 2007·Toxicology Mechanisms and Methods·Jessica N MazerikNarasimham L Parinandi
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Shuangqing PengWilliam D Atchison
Mar 12, 2020·Journal of Neurophysiology·Michael P SceniakWilliam D Atchison
Jun 17, 2020·Antioxidants & Redox Signaling·Shingo Kasamatsu
Nov 6, 2007·The Journal of Pharmacology and Experimental Therapeutics·Christina J HerdenWilliam D Atchison
Feb 15, 2021·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Mahendra YadavNidhi Sandal
Aug 11, 2000·Toxicology and Applied Pharmacology·J E Sirois, W D Atchison
May 16, 2021·Molecular Neurobiology·Gabriela de Paula ArrifanoMaria Elena Crespo-Lopez
Aug 25, 2017·Chemical Research in Toxicology·Hideshi IharaTakaaki Akaike
Jan 7, 2022·Chemical Research in Toxicology·Jingjing PanWei Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.